Jayasree K. Iyer comments on GSK’s approach to IP and Patents on Access to Medicine

Financial Times

Jayasree K. Iyer shares her views on the announcement made by Sir Andrew Witty regarding GSK’s “graduated approach” to Intellectual Property and Patents. She also discusses the overall impact of the approach on the pharmaceutical industry.

Follow us and engage with us on LinkedIn and Twitter.